ETV4 overexpression could transactivate LOXL2 and recruit it to the promoter region of NID1 to mediate the demethylation and expression of NID1, which in turn activates ERK pathway and promotes CRC cell growth, metastasis and EMT. Here, LOXL2 is linked to colorectal carcinoma.